Who are Sodium hyaluronate eye drops's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Systane Hydration PF, Meticel Ofteno® 0.5%, Systane Complete PF, Ophthalmic Emulsion, Optive®, PEG- 400 based artificial tear.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-hyaluronate-eye-drops.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Sodium hyaluronate eye drops — Competitive Intelligence Brief

Sodium hyaluronate eye drops (Sodium hyaluronate eye drops) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / ocular lubricant. Area: Ophthalmology.

marketed Artificial tear / ocular lubricant Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Sodium hyaluronate eye drops (Sodium hyaluronate eye drops) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. Sodium hyaluronate forms a protective, lubricating film on the ocular surface to retain moisture and reduce friction.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Sodium hyaluronate eye drops TARGET	Sodium hyaluronate eye drops	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	marketed	Artificial tear / ocular lubricant
Systane Hydration PF	Systane Hydration PF	University of Alabama at Birmingham	marketed	Artificial tear / Ocular lubricant
Meticel Ofteno® 0.5%	Meticel Ofteno® 0.5%	Laboratorios Sophia S.A de C.V.	marketed	Artificial tear / Ocular lubricant
Systane Complete PF	Systane Complete PF	University of California, Berkeley	marketed	Artificial tear / Ocular lubricant
Ophthalmic Emulsion	Ophthalmic Emulsion	Allergan	marketed	Artificial tear / Ocular lubricant
Optive®	Optive®	Laboratorios Sophia S.A de C.V.	marketed	Artificial tear / Ocular lubricant
PEG- 400 based artificial tear	PEG- 400 based artificial tear	Bp Consulting, Inc	marketed	Artificial tear / Ocular lubricant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / ocular lubricant class)

Allergan · 2 drugs in this class
Chang Gung Memorial Hospital · 1 drug in this class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Medical University of Vienna · 1 drug in this class
Nguyen Viet Giap · 1 drug in this class
ORA, Inc. · 1 drug in this class
Ocusoft, Inc. · 1 drug in this class
The Mentholatum Company · 1 drug in this class
Tianjin Eye Hospital · 1 drug in this class
University of Sao Paulo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium hyaluronate eye drops — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-hyaluronate-eye-drops. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab